Esophageal stents during neoadjuvant therapy

Esophageal stents during neoadjuvant therapy review Eur Surg (2017) 49:149–157 DOI 10.1007/s10353-017-0471-3 A systematic review Guillermo Becerril-Martinez · Gregory L. Falk · Mario D’Souza Received: 5 June 2016 / Accepted: 21 February 2017 / Published online: 24 March 2017 © Springer-Verlag Wien 2017 Summary Results Our literature search identified 425 potentially Background Stents are widely used in the pallia- relevant reports and articles on patients who had un- tive treatment of esophageal malignant diseases for dergone stenting in neoadjuvant therapy, of which dysphagia. Their safety and efficacy in the curative 14 studies (n = 430 patients) met the inclusion cri- neoadjuvant setting while induction therapy is under- teria for analysis. A total of 430 patients were iden- way have not been established. Concerns have been tified undergoing stenting and neoadjuvant therapy raised about a low frequency of curative surgery and with intention to cure. Resection was determined in poor survival outcomes when stenting has been used 250 patients in a highly heterogeneous group and was as a pathway to neoadjuvant therapy. achieved in 46.9% of patients (95% CI: 22.8–71.8). The Methods A systematic review was undertaken to variability of the resection proportion in the reports identify patients with esophageal cancer undergo- was very wide. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Surgery Springer Journals

Esophageal stents during neoadjuvant therapy

Loading next page...
 
/lp/springer_journal/esophageal-stents-during-neoadjuvant-therapy-qk3l10bply
Publisher
Springer Vienna
Copyright
Copyright © 2017 by Springer-Verlag Wien
Subject
Medicine & Public Health; Surgery; Abdominal Surgery; Cardiac Surgery; General Surgery; Vascular Surgery
ISSN
1682-8631
eISSN
1682-4016
D.O.I.
10.1007/s10353-017-0471-3
Publisher site
See Article on Publisher Site

Abstract

review Eur Surg (2017) 49:149–157 DOI 10.1007/s10353-017-0471-3 A systematic review Guillermo Becerril-Martinez · Gregory L. Falk · Mario D’Souza Received: 5 June 2016 / Accepted: 21 February 2017 / Published online: 24 March 2017 © Springer-Verlag Wien 2017 Summary Results Our literature search identified 425 potentially Background Stents are widely used in the pallia- relevant reports and articles on patients who had un- tive treatment of esophageal malignant diseases for dergone stenting in neoadjuvant therapy, of which dysphagia. Their safety and efficacy in the curative 14 studies (n = 430 patients) met the inclusion cri- neoadjuvant setting while induction therapy is under- teria for analysis. A total of 430 patients were iden- way have not been established. Concerns have been tified undergoing stenting and neoadjuvant therapy raised about a low frequency of curative surgery and with intention to cure. Resection was determined in poor survival outcomes when stenting has been used 250 patients in a highly heterogeneous group and was as a pathway to neoadjuvant therapy. achieved in 46.9% of patients (95% CI: 22.8–71.8). The Methods A systematic review was undertaken to variability of the resection proportion in the reports identify patients with esophageal cancer undergo- was very wide.

Journal

European SurgerySpringer Journals

Published: Mar 24, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off